Glibenclamide is often used as an insulin stimulant
in many studies and also used as a standard antidiabetic drug in
STZ-induced moderate diabetes to compare the antidiabetic properties
of a variety of hypoglycemic compounds (Andrade Cetto
et al., 2000).